Pyxis Oncology logo

Pyxis Oncology

PYXS | NASDAQ
Chart Builder DCF Calculator
$1.41
-$0.17 (-10.76%)
At close: Nov 16, 2026, 4:00 PM ET
$1.43
+$0.02 (+1.29%)
After-hours: Nov 16, 2026, 7:06 PM ET
-10.76%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
33.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #701/1021 (Top 69%)

Key Statistics

Market Data

Market Cap $168.65M
1D Range
1.41 1.56
52W Range
1.06 5.34

Valuation (TTM)

PE -1.08
PB 4.08
EV/EBITDA -1.58

Valuation (NTM)

Forward PE N/A
Forward PEG 0.07
Price Target $7.50
Loading financial charts...

Profile

Pyxis Oncology, Inc. operates as a preclinical biopharmaceutical company focused on developing novel therapeutic approaches to combat various forms of cancer. Its investigational immune-oncology pipel...

Sector Healthcare
Industry Biotechnology
Employees 56
IPO Date Oct 8, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
7
Consensus
Buy
Price Target
$7.50
Upside
+431.91%
Buy (7)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.